Why Some Doctors Dismiss Chronic Lyme Disease
Persistent symptoms remain medically controversial
Differences in training and evidence shape physician opinions
Patients deserve careful evaluation and shared decision-making
Many patients living with persistent symptoms after Lyme disease describe a frustrating experience. They continue to struggle with fatigue, pain, cognitive problems, dizziness, or other disabling symptoms, yet some are told that Lyme disease can no longer explain what they are experiencing.
Why do physicians evaluating similar patients sometimes reach very different conclusions? The answer is complex. Differences in medical training, interpretation of scientific evidence, clinical experience, and healthcare systems all influence how physicians approach patients with persistent Lyme disease symptoms.
Understanding these differences helps explain why some patients feel dismissed while others receive more individualized evaluation and care.
Medical Training Shapes Clinical Thinking
Most physicians are trained to diagnose illnesses that fit well-defined patterns supported by established diagnostic tests and treatment guidelines.
Lyme disease does not always follow that model.
Many patients recover completely after recommended antibiotic treatment. Others continue to experience persistent fatigue, musculoskeletal pain, cognitive dysfunction, autonomic symptoms, or neurologic complaints despite appropriate therapy.
When symptoms persist after standard treatment, physicians may interpret the situation differently depending on their training and clinical experience.
Some clinicians view persistent symptoms primarily as postinfectious or inflammatory. Others consider a broader range of possibilities, including persistent immune activation, coinfections, autonomic dysfunction, microbiome changes, persistent bacterial antigens, persistent infection in selected patients, or unrelated medical conditions that require further evaluation.
Because no single mechanism explains every patient, persistent symptoms remain an area of ongoing scientific investigation.
For additional discussion of why Lyme disease challenges traditional medical models, see Why Lyme Disease Tests the Limits of Medicine.
Different Guidelines Lead to Different Conclusions
Professional guidelines also influence how physicians manage persistent Lyme disease symptoms.
Some guidelines emphasize that persistent symptoms usually reflect postinfectious mechanisms and generally recommend against prolonged antibiotic therapy. Other organizations recognize that selected patients may benefit from individualized treatment decisions based on clinical presentation, response to therapy, and physician judgment.
These differing recommendations contribute to substantial variation in clinical practice.
Patients are often unaware that physicians may be following different evidence reviews and clinical guidelines when recommending treatment.
Scientific Uncertainty Remains
One reason opinions differ is that important scientific questions remain unanswered.
Researchers continue to investigate why some patients experience prolonged symptoms after Lyme disease while others recover completely.
Proposed mechanisms include:
- Persistent inflammatory responses
- Immune dysregulation
- Persistent bacterial antigens
- Persistent infection in selected patients
- Tick-borne coinfections
- Autonomic nervous system dysfunction
- Microbiome alterations
- Other unrelated medical conditions
Rather than supporting a single explanation, current research suggests that persistent symptoms are likely heterogeneous and may arise through multiple biologic pathways.
For a more detailed discussion of these proposed mechanisms, see Persistent Lyme Disease Mechanisms.
Terminology Can Influence Perception
The words physicians use also influence how patients perceive their illness.
Some clinicians prefer the term post-treatment Lyme disease syndrome (PTLDS), while others use terms such as persistent Lyme disease or chronic manifestations of Lyme disease.
Although terminology differs, many physicians agree on an important point: persistent symptoms are real and deserve thoughtful evaluation, even when experts disagree about their underlying cause.
For readers interested in the terminology debate, see Is Chronic Lyme Disease Real?.
Why Some Patients Feel Dismissed
When symptoms continue despite treatment and no single explanation is apparent, patients may feel their concerns are minimized or attributed solely to stress, aging, anxiety, fibromyalgia, or other chronic conditions.
While these diagnoses may be appropriate in some individuals, they should not replace a careful reassessment of patients whose clinical picture continues to evolve.
In my clinical practice, I have found that persistent symptoms often warrant a broader evaluation, including consideration of coinfections, autonomic dysfunction, inflammatory disorders, medication effects, and other medical conditions that may coexist with Lyme disease.
The Challenge of Caring for Patients With Persistent Symptoms
Persistent symptoms after Lyme disease present one of the greatest challenges in clinical medicine.
Patients often return after completing recommended therapy because fatigue, pain, cognitive dysfunction, dizziness, or other symptoms have not resolved. Standard laboratory tests may no longer provide clear answers, leaving physicians to interpret an evolving clinical picture with incomplete scientific evidence.
A comprehensive review by Marques notes that persistent symptoms following Lyme disease are likely heterogeneous and may reflect multiple biologic mechanisms rather than a single explanation. Proposed contributors include persistent inflammatory responses, immune dysregulation, coinfections, microbiome alterations, persistence of bacterial antigens, persistent infection in selected patients, or unrelated medical conditions that warrant separate evaluation.
Because no single mechanism explains every patient, individualized clinical assessment remains essential.
Shared Decision-Making Matters
When evidence is incomplete, the physician-patient relationship becomes even more important.
Shared decision-making is a collaborative process in which physicians integrate the best available scientific evidence with each patient’s goals, values, preferences, and clinical circumstances. Rather than relying on rigid treatment algorithms, physicians and patients review the potential benefits, risks, alternatives, and uncertainties together before deciding on a management plan.
This approach recognizes that patients with persistent symptoms may not all follow the same recovery pathway. It also encourages ongoing reassessment as new symptoms develop or new evidence becomes available.
In my own practice, I have found that careful follow-up and individualized reassessment often identify contributing factors that were not initially apparent. Some patients improve after treatment of recognized tick-borne coinfections, while others benefit from addressing autonomic dysfunction, inflammatory conditions, or other overlapping illnesses.
Shared decision-making does not eliminate uncertainty, but it helps ensure that patients remain active participants in their care rather than feeling dismissed when straightforward answers are unavailable.
Clinical Experience and Physician Perspective
Physicians who regularly evaluate patients with tick-borne illnesses may encounter a broader spectrum of clinical presentations than physicians who primarily see uncomplicated early Lyme disease.
These differences in clinical experience can influence how persistent symptoms are interpreted and managed.
Physicians’ clinical experience often differs depending on the patient populations they serve. Some primarily encounter patients who recover promptly after treatment, while others frequently evaluate patients referred because symptoms have persisted despite prior therapy.
As a result, experienced clinicians may reasonably differ in how they approach persistent symptoms while remaining committed to evidence-based medicine.
Moving Beyond the Debate
The ongoing debate surrounding chronic Lyme disease should not distract from the needs of individual patients.
Whether persistent symptoms reflect ongoing inflammation, immune dysregulation, coinfections, persistent infection in selected patients, or other mechanisms, patients deserve thoughtful evaluation and compassionate care.
Scientific uncertainty should encourage careful investigation rather than premature conclusions.
As research advances, physicians will continue refining their understanding of why recovery varies so widely among patients with Lyme disease.
Frequently Asked Questions
Why do some doctors dismiss chronic Lyme disease?
Physicians often interpret persistent Lyme disease symptoms differently because of differences in medical training, clinical experience, treatment guidelines, and evolving scientific evidence. While experts disagree about the underlying mechanisms, many agree that persistent symptoms deserve careful evaluation.
Is chronic Lyme disease the same as post-treatment Lyme disease syndrome (PTLDS)?
Not necessarily. Some physicians use the term post-treatment Lyme disease syndrome (PTLDS), while others use persistent Lyme disease or chronic manifestations of Lyme disease. Although terminology differs, all recognize that some patients experience persistent symptoms after Lyme disease.
Why do doctors disagree about treatment?
Different professional organizations interpret the available scientific evidence differently. Some emphasize postinfectious mechanisms, while others support individualized treatment decisions in selected patients based on clinical judgment and patient response.
Can persistent symptoms have more than one cause?
Yes. Current research suggests that persistent symptoms are likely heterogeneous and may involve multiple contributing mechanisms, including immune dysregulation, persistent inflammatory responses, autonomic dysfunction, coinfections, persistent infection in selected patients, or unrelated medical conditions.
What should patients do if symptoms continue?
Patients whose symptoms persist should discuss ongoing concerns with a healthcare professional experienced in evaluating Lyme disease and other possible causes of persistent illness. Continued reassessment and shared decision-making are often important when recovery does not follow the expected course.
Clinical Takeaway
Persistent symptoms after Lyme disease remain one of the most challenging areas of modern medicine. Differences in physician training, clinical experience, professional guidelines, and evolving scientific evidence all contribute to why some doctors reach different conclusions when evaluating similar patients.
Although important questions remain unanswered, patients deserve careful evaluation, respectful communication, and shared decision-making. Scientific uncertainty should encourage thoughtful reassessment rather than premature dismissal of persistent symptoms.
Related Articles
Learn more about persistent symptoms, ongoing research, and individualized Lyme disease care:
Is Chronic Lyme Disease Real?
Why Lyme Disease Tests the Limits of Medicine
Persistent Lyme Disease Mechanisms
Post-Treatment Lyme Disease Syndrome (PTLDS)
Recovery From Lyme Disease
References
- Marques A. Persistent Symptoms After Treatment of Lyme Disease. Infect Dis Clin North Am. 2022;36(3):701-714.
- Hoque F. Shared Decision-Making in Patient Care: Advantages, Barriers and Potential Solutions. J Brown Hosp Med. 2024;3(4):13-15.
- Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin Infect Dis. 2021;72(1):e1-e48.
- Cameron DJ, Johnson LB, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther. 2014;12(9):1103-1135.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
